Spencer S. Eccles Health Sciences Library, University of Utah
Abstract
Patients with Li-Fraumeni Syndrome (LFS) are at a high risk of cancer; Lifetime risk of cancer approaches 90%; Recent data suggest that early cancer surveillance is beneficial for patients with LFS
